Ledger.Open graph →
SEC Form D · filed October 27, 2022

Odyssey Therapeutics, Inc

Offering
$174.9M
Sold
$168.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Valerie D. Odegard · MEDFIELD, MADirectorJill D. Carroll · MEDFIELD, MADirectorCarl D. Gordon · MEDFIELD, MADirectorJeffrey D. Leiden · Cambridge, MADirectorCharles D. Baum · Cambridge, MADirectorGary D. Glick · MEDFIELD, MAExec · DirectorValerie D. Odegard · MEDFIELD, MADirectorJill D. Carroll · MEDFIELD, MADirectorCarl D. Gordon · MEDFIELD, MADirectorJeffrey D. Leiden · Cambridge, MADirectorCharles D. Baum · Cambridge, MADirectorGary D. Glick · Boston, MAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗